Skip to main content
. 2023 Jun 24;13:10257. doi: 10.1038/s41598-023-37333-4

Table 3.

Standardized mortality ratios for each cause of death following regional melanoma diagnosis.

Cause of death Timing of deaths after diagnosis
 < 1 year 1 to < 5 years 5 to < 10 years  ≥ 10 years Total
Observed SMR (95% CI) Observed SMR (95% CI) Observed SMR (95% CI) Observed SMR (95% CI) Observed SMR (95% CI)
All 1697 3.34 (3.19–3.51)b 4591 5.93 (5.76–6.11)b 1977 3.83 (3.67–4.01)b 2372 1.88 (1.8–1.96)b 10,637 3.48 (3.41–3.54)b
Melanoma 1227 6.16 (5.82–6.51)b 5068 15.88 (15.45–16.33)b 978 12.69 (11.91–13.51)b 189 11.37 (9.81–13.12)b 7462 12.19 (11.92–12.47)b
Non-melanoma cancers 32 0.47 (0.32–0.66)b 246 1.15 (1.01–1.3)b 152 0.98 (0.83–1.15) 96 0.98 (0.8–1.2) 526 0.98 (0.9–1.07)
Non-cancer 438 1.86 (1.69–2.04)b 1254 1.69 (1.59–1.78)b 602 1.11 (1.02–1.2)b 355 0.98 (0.88–1.09) 2649 1.41 (1.35–1.46)b
In situ, benign or unknown behavior neoplasm 3 1.51 (0.31–4.41) 6 0.96 (0.35–2.09) 5 1.09 (0.35–2.55) 2 0.67 (0.08–2.41) 16 1.01 (0.58–1.64)
Tuberculosis 0 0 (0–70.22) 1 6.43 (0.16–35.83) 0 0 (0–34.87) 0 0 (0–56.77) 1 2.64 (0.07–14.71)
Septicemia 8 1.92 (0.83–3.78) 27 2.05 (1.35–2.98)b 13 1.35 (0.72–2.3) 8 1.25 (0.54–2.47) 56 1.68 (1.27–2.18)b
Other infectious and parasitic diseases including HIV 3 1.22 (0.25–3.57) 9 1.14 (0.52–2.17) 5 0.88 (0.29–2.05) 2 0.59 (0.07–2.12) 19 0.98 (0.59–1.53)
Diabetes mellitus 16 1.91 (1.09–3.1)b 57 2.14 (1.62–2.77)b 31 1.61 (1.1–2.29)b 14 1.11 (0.61–1.86) 118 1.77 (1.46–2.11)b
Alzheimer’s (ICD-9 and 10 only) 20 1.72 (1.05–2.66)b 51 1.32 (0.99–1.74) 37 1.23 (0.87–1.7) 21 0.94 (0.58–1.43) 129 1.26 (1.05–1.5)b
Diseases of heart 170 2.05 (1.75–2.38)b 470 1.85 (1.69–2.03)b 189 1.05 (0.91–1.21) 116 0.99 (0.82–1.18) 945 1.49 (1.4–1.59)b
Hypertension without heart disease 5 1.59 (0.52–3.72) 19 1.84 (1.11–2.87)b 7 0.89 (0.36–1.83) 3 0.54 (0.11–1.57) 34 1.26 (0.87–1.76)
Cerebrovascular diseases 34 1.96 (1.36–2.74)b 108 2.04 (1.68–2.47)b 51 1.36 (1.01–1.79)b 29 1.15 (0.77–1.66) 222 1.67 (1.46–1.91)b
Atherosclerosis 3 2.59 (0.53–7.58) 7 2.25 (0.9–4.63) 3 1.55 (0.32–4.53) 4 3.61 (0.98–9.23) 17 2.32 (1.35–3.72)b
Aortic aneurysm and dissection 3 1.96 (0.4–5.73) 8 1.79 (0.77–3.53) 0 0 (0–1.26) 0 0 (0–2.11) 11 1.03 (0.51–1.85)
Other diseases of arteries, arterioles, capillaries 3 2.55 (0.53–7.47) 4 1.11 (0.3–2.83) 2 0.78 (0.09–2.81) 2 1.18 (0.14–4.27) 11 1.21 (0.61–2.17)
Pneumonia and influenza 15 1.98 (1.11–3.26)b 37 1.63 (1.15–2.25)b 18 1.15 (0.68–1.82) 13 1.29 (0.69–2.21) 83 1.48 (1.18–1.84)b
Chronic obstructive pulmonary disease and allied conditions 26 1.38 (0.9–2.02) 56 0.93 (0.7–1.21) 24 0.54 (0.35–0.81)b 16 0.55 (0.31–0.89)b 122 0.8 (0.67–0.96)b
Stomach and duodenal ulcers 0 0 (0–8.98) 2 1.63 (0.2–5.88) 0 0 (0–4.34) 0 0 (0–6.69) 2 0.66 (0.08–2.38)
Chronic liver disease and cirrhosis 10 3.05 (1.46–5.6)b 19 1.73 (1.04–2.71)b 7 0.86 (0.35–1.77) 3 0.57 (0.12–1.66) 39 1.41 (1–1.93)b
Nephritis, nephrotic syndrome and nephrosis 10 1.73 (0.83–3.18) 34 1.87 (1.29–2.61)b 16 1.21 (0.69–1.97) 14 1.63 (0.89–2.74) 74 1.62 (1.27–2.03)b
Complications of pregnancy, childbirth, puerperium 1 70.44 (1.78–392.46)b 1 21.39 (0.54–119.18) 1 29.63 (0.75–165.08) 0 0 (0–193.21) 3 26.36 (5.44–77.05)b
Congenital anomalies 0 0 (0–11.86) 1 1.01 (0.03–5.64) 0 0 (0–5.26) 0 0 (0–8.23) 1 0.41 (0.01–2.28)
Symptoms, signs and ill-defined conditions 1 0.28 (0.01–1.57) 21 1.87 (1.16–2.85)b 11 1.31 (0.66–2.35) 6 1.18 (0.43–2.56) 39 1.38 (0.98–1.89)
Accidents and adverse effects 13 1.28 (0.68–2.18) 50 1.49 (1.1–1.96)b 23 0.93 (0.59–1.39) 15 0.91 (0.51–1.5) 101 1.19 (0.97–1.44)
Suicide and self-inflicted injury 16 5.66 (3.24–9.2)b 22 2.38 (1.49–3.6)b 12 1.79 (0.93–3.13) 7 1.7 (0.68–3.51) 57 2.49 (1.89–3.23)b
Homicide and legal intervention 1 2.26 (0.06–12.61) 0 0 (0–2.67) 1 1.07 (0.03–5.98) 0 0 (0–7.04) 2 0.61 (0.07–2.2)
Other cause of death 77 1.65 (1.31–2.07)b 244 1.59 (1.4–1.8)b 146 1.24 (1.05–1.46)b 80 0.97 (0.77–1.21) 547 1.37 (1.26–1.49)b

1Number of cancer patients who died due to each cause of death.

295% Confidence interval.

bP-value < 0.05.